Johnson & Johnson begins final phase of single-shot COVID-19 vaccine study Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. September 23, 2020 Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment